Osimertinib is a game changer in NSCLC

from Medical News Podcast · host PeerDirect

How does lung cancer immunotherapy osimertinib affect 5-year survival? Find out about this and more in today's PV Roundup podcast.

Episode metadata supplied by the publisher feed · Published Jun 13, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Osimertinib is a game changer in NSCLC

0:00 3:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 3 minutes long.

This episode was published on June 13, 2023.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!